Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #642011 on NorthWest Biotherapeutics Inc (NWBO)
ae kusterer
10/19/23 2:31 PM
#642013 RE: HappyLibrarian #642011
newman2021
10/19/23 2:35 PM
#642016 RE: HappyLibrarian #642011
JimSmith111
#642017 RE: HappyLibrarian #642011
antihama
10/20/23 10:09 AM
#642132 RE: HappyLibrarian #642011
“We are delighted to have Dr. Liau join our existing distinguished SAB. Her experience as a leader in the neuro-oncology field, her decades of research and knowledge of both brain cancer biology and immunotherapies, and her extensive experience with DCVax-L as the Principal Investigator of the Phase 3 trial, will be invaluable as we work together on DCVax-L approval and on future clinical programs building on that.”